Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open‐label, crossover trial
用户sGjaISN0bR0M
1个月前
87
10
已完结
1. 系统已在2026-09-19 16:12:18对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1111/dom.15180
文献链接: https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15180
其他信息:
出版社: Wiley
作者: Jens Christian Laursen; Viktor Rotbain Curovic; Marjolein Y. A. M. Kroonen; Niels Jongs; Emilie H. Zobel; Tine W. Hansen; Marie Frimodt‐Møller; Gozewijn D. Laverman; Adriaan Kooy; Frederik Persson; Hiddo J. L. Heerspink; Christian Stevns Hansen; Peter Rossing
